期刊文献+

t(12;21)儿童急性淋巴细胞白血病发病机制的研究进展 被引量:3

下载PDF
导出
摘要 t(12;21)(p13;q22)是儿童急性淋巴细胞白血病最常见的染色体易位,易位形成的TEL-AML1融合基因在白血病发病中起重要作用。TEL-AML1融合蛋白能募集N-CoR、roSin3和SMRT等核辅助抑制因子,与TEL蛋白形成异二聚体而干扰野生型TEL蛋白的功能,并与野生型AML1竞争AML1结合位点而起显著负性抑制作用。t(12;21)可能是致白血病的必要的初始遗传事件之一,其他细胞遗传学异常、尤其是未易位的TEL等位基因缺失,对疾病的发生、发展起着重要的促进作用。
作者 林冬 王建祥
出处 《国外医学(输血及血液学分册)》 2004年第2期137-140,共4页 Foreign Medical Sciences(Section of Blood Transfusion and Heanatology)
  • 相关文献

参考文献26

  • 1Shurtleff SA, Buijs A, Behm FG, et al. TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis. Leukemia, 1995, 9: 1985-1989.
  • 2Mclean TW, Ringold S, Neuberg D, et al. TEL-AML1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia. Blood, 1999, 88:4252-4258.
  • 3Golub TR, Barker GF. Bohlander SK, et al. Fusion of the TEL gene on 12p13 to the AMLI gene on 21q22 in acute lymphoblastic leukemia. Proc Natl Acad Sci U S A, 1995, 92:4917-4921.
  • 4Trka J, Zuna J, Hrusak O, et al. Correspondence: impact of TEL/AML1-positive patients on age distribution of childhood acute lymphoblastic leukemia in Czech Republic. Leukemia, 1998, 12:996-997.
  • 5Golub TR, Barker GF, Lovett M, et al. Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12)chromosomal translocation. Cell, 1994, 77:307-316.
  • 6Rubnitz JE, Pui CH, Downing JR. The role of TEL genes in pediatric leukemias. Leukemia, 1999, 13:6-13.
  • 7Chakrabarti SR, Sood R, Nandi S, et al. Posttranslational modification of TEL and TEL/AML1 by SUMO-1 and cell cycledependent assembly into nuclear bodies. Pro Natl Acad Sci U S A,2000, 97(24) :13291-13285.
  • 8Guidez F, Retrie K, Ford AM, et al. Recruitment of the nuclear receptor corepressor N-CoR by the TEl. moiety of the childhood leukemia-associated TEL-AML1 oncoprotein. Blood, 2000, 96(7) :2557-2561.
  • 9Wang LC, Kuo F, Fujiwara Y, et al. Yolk sac anfiiogenic defect and intro-embryonic apoptosis in mice lacking the Ets-related factor TEL. EBMO j, 1997, 16:4374-4383.
  • 10Wang LC, Swat W, Fujiwara Y, et al. The TEL/ETV6 gene is required specifically for hematopoiesis in the bone marrow. Genes Dev, 1998, 12:2392-2402.

同被引文献32

  • 1赵佳炜(综述),王敏(审校).MLL基因重排及其新伙伴基因的检出方法[J].国际输血及血液学杂志,2007,30(1):70-73. 被引量:1
  • 2Scherr M, et al. Specific inhibition of bcr - abl gene expression by small interfering RNA. Blood, 2003, 101 (4) :1566 -1569.
  • 3Chen J, et al. Stable expression of small interfering RNA sensitizes TEL - PDGFbetaR to inhibition with imatinib or rapamycin. J Clin Invest, 2004,113(12) :1784 - 1791.
  • 4Ptasznik A ,et al. Short interfering RNA (siRNA) targeting the Lyn ki- nase induces apoptosis in primary, and drug - resistant, BCR - ABL1 ( + ) leukemia cells. Nat Med, 2004,10(11) :1187 -1189.
  • 5Heidenreich O,et al. AMLI/MTG8 oncogene suppression by small interfering RNAs supports myeloid differentiation of t( 8 ;21 ) - positive leukemic cells. Blood, 2003,101 ( 8 ) : 3157 - 3163.
  • 6Downing J R. The AML1 - ETO chimaeric transcription factor in acute myeloid leukaemia: biology and clinical significance. Br J Haematol, 1999,106(2) :296 -308.
  • 7M iyoshi H, et al. The t (8 ;21 ) translocation in acute myeloid leukemia results in production of an AML1 - MTG8 fusion transcript. Embo J, 1993,12(7) :2715 -2721.
  • 8Dunne J,et al. siRNA - mediated AML1/MTG8 depletion affects differentiation and proliferation- associated gene expression in t( 8 ;21 ) -positive cell lines and primary AML blasts. Oncogene, 2006,25 (45) :6067 - 6078.
  • 9Kasashima K,E Sakota, T Kozu. Discrimination of target by siRNA: designing of AML1 - MTG8 fusion mRNA - specific siRNA sequences. Biochimie, 2004,86(9 - 10) :713 -721.
  • 10Ziemin - van der Poel S,et al. Identification of a gene, MLL, that spans the breakpoint in 11 q23 translocations associated with human leukemias. Proc Natl Acad Sci U S A, 1991,88 (23) :10735 -10739.

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部